Some of the sphingomonads (especially Sphingomonas paucimobilis) also play a role in human disease, primarily by causing a range of mostly nosocomial, non-life-threatening infections that typically are easily treated by antibiotic therapy.[2][3]
Due to their biodegradative and biosynthetic capabilities, sphingomonads have been utilised for a wide range of biotechnological applications, from bioremediation of environmental contaminants to production of extracellular polymers such as sphingans (e.g., gellan, welan, and rhamsan) used extensively in the food and other industries[citation needed]. The shorter carbohydrate moiety of GSL compared to that of LPS results in the cell surface being more hydrophobic than that of other Gram-negative bacteria, probably accounting for both Sphingomonas' sensitivity to hydrophobic antibiotics and its ability to degrade hydrophobic polycyclic aromatic hydrocarbons.[1] One strain, Sphingomonas sp. 2MPII, can degrade 2-methylphenanthrene.[4] In May 2008, Daniel Burd, a 16-year-old Canadian, won the Canada-Wide Science Fair in Ottawa after discovering that Sphingomonas can degrade over 40% of the weight of plastic bags (Polyethylene) in less than three months.[